CD274 and multiple sclerosis: Some of them focused on the pathogenesis and therapeutic mechanisms of EBV (e.g., “apoptosis”, “rituximab”, “PD-L1”, “immunotherapy”), and some focused on EBV-associated disease (e.g., “multiple sclerosis”, “gastric cancer”).